RBFC
ZBH icon

Roman Butler Fullerton & Co’s Zimmer Biomet ZBH Stock Holding History

Roman Butler Fullerton & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,685
Closed -$367K – 282
2025
Q3 		$367K Sell
3,685
-160
-4% -$15.9K 0.1% 186
2025
Q2 		$375K Sell
3,845
-322
-8% -$31.1K 0.11% 170
2025
Q1 		$405K Sell
4,167
-34
-0.8% -$3.64K 0.16% 145
2024
Q4 		$473K Buy
+4,201
New +$451K 0.15% 143

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Roman Butler Fullerton & Co's ZBH Position: Q4 2025 in Review

Roman Butler Fullerton & Co sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 3,685 shares — an estimated $367K sold.

Roman Butler Fullerton & Co first reported a position in ZBH in Q4 2024 and held it in 4 quarters. The position peaked at $473K in Q4 2024. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Roman Butler Fullerton & Co reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 3,685 Zimmer Biomet shares in Q4 2025, an estimated $367K.
  • Roman Butler Fullerton & Co first reported a position in Zimmer Biomet in Q4 2024 and held it in 4 quarters.
  • Roman Butler Fullerton & Co's Zimmer Biomet position peaked at $473K in Q4 2024.
  • 949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2025, filed 26 Jan 2026.